Summary. Glipizide stimulates insulin release from incubated pieces of rat pancreatic tissue. The dose-action relationship is characterized by an EDs0 of approximately 0.04 ~M, comparable to that of glibenelamide or glisoxepide. Like other sulphonylureas, the insulinotropie action of glipizide over 60 rain incubation is barely detectable in the absence of glucose, maximal at intermediate glucose concentrations (1.0 to 1.5 mg/ml), and present but short-lived at a higher glucose level (3.0 mg/ml).
Glipizide was recently proposed as a new hypoglycemic sulphonylurea [1] . The aim of the present note is to evaluate the insulinotropic potency of this compound, using a method for the measurement of insulin secretion by incubate.d pieces of rat pancreatic tissue [6] .
Materials and Methods
Small pieces of pancreatic tissue (approximately 8 mg each), removed from fed rats, were incubated for 30 or 60 rain at 37~ in groups of 4: pieces each in bicarbonate-buffered media (2 ml) equilibrated against a mixture of 02 (95%) and CO~ (5~o), and containing bovine albumin (5 mg/ml), guinea-pig anti-insulin serum (kindly donated by Dr. P.H. Wright, Indiana University, Indianapolis), and as required, glucose and glipizide (K-4024 or N-{4-[fl-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzene-sulphonyl}-N'-cyclohexylurea; Pfizer, Brussels). The amount of insulin released into the medium was deduced from the partial neutralization of the insulin antibodies [6] and expressed as txU insulin secreted per mg of incubated tissue over the stated period of incubation. In all experiments, an equal number of determinations (n) were performed in media containing glucose alone and in media containing both glucose and glipizide. The increments in insulin release attributable to glipizide (df = 2n --2) after 30 or 60 min incubation were used to calculate the sulphonylurea-indueed increments in secretion rate during each period of incubation.
Results
At a glucose concentration of 1.0 mg/ml, the rate of insulin secretion was close to that found in the absence of glucose, and averaged 7.2 ~ 1.6 ~U/mg per 60 rain (n = 36). As the glucose concentration was increased to 1.5 and 3.0 mg/ml, the rate of insulin release increased to 20.7 • 3.0 (n = 48) and 60.8 ~ 4.5 (n = 31) ~U/mg per 60 rain respectively. At a low glucose level (1.0 mg/ml), the dose-action relationship for the insulinot]:opie effect of glipizide was characterized by a threshold value at concentrations ranging between 10 -6 and 10 -5 mg/ml, and a maximal effect in the range between 1@ 4 and 10 -3 mg/ml (Table 1 and Fig. 1 ). When the insnlinotropic action of glipizide (10 -~ mg/ml) was tested at various glucose concentrations (Table 1) , the increments in insulin output attributable to the drug were of doubtful significance in the absence of glucose and at high glucose concentration (3.0 mg/ml) but quite obvious at intermediate glucose levels (1.0 and t.5 mg/ml). The failure of glipizide to cause a significant increase in insulin release at high glucose concentration (Table 1 , last line is A. Herchuelz and W.J. Malaisse Insulinotropic Potency of Glipizide only apparent). Indeed, the increment in secretion rate induced by glipizide was much more marked when estimated over a shorter period of incubation (30 rain). Thus, in this initial period (0 to 30 rain), glipizide provoked a significant increase in insulin output (q-9.7 :~ 4.1 ~U/mg/30 rain; n = 3.0; p< 0.025) in excess of that evoked by glucose alone (3.0 mg/ml), whereas no further effect of the sulphonylurea (--0.2 ~U/mg/30 rain) could be detected during the second period of incubation (30 to 60 rain).
. 
Discussion
The data illustrated in Table 1 and Fig. 1 indicate that glipizide is a potent insulinotropie sulphonylurea. As previously observed with glibenelamide or glisoxepide [2, 4] , the minimal effective dose of glipizide ranges between 10 -G and 10 -5 mg/ml; and maximal insulinotropie action is achieved at concentrations of 10 -4 to 10 -a mg/ml. Between these concentrations, the EDs0 was calculated from the regression of the increments in insulin secretion rate on the logarithmic values for glipizide concentration. The EDs0 for the insulinotropie action of this compound approximated 18 ng/ml or 0.04 ~M, a value comparable to that previously found with this technique for glibenelamide and glisoxepide and much lower than that observed for glielazide or glycodiazin [3] . The modulation of the insulinotropie action of glipizide by the glucose concentration of the incubation medium (Table 1) is similar to that reported for other hypoglycemie sulphonylureas and su]lonamides [2, 3, 4, 5] . In all cases, the insulinotropic effect is small and occasionally insignificant in the absence of glucose, and reaches its maximal value at glucose concentrations of 1.0 or 1.5 mg/ml. Our data also indicate that the insulinotropic action of glipizide, like that of tolbutamide, glyeodiazin and glisoxepide [2, 4, 5] , fades out rather rapidly at a high glucose concentration (3:0 mg/ml). These converging findings support the concept that the sulphonylureas have a common mode and site of action in the pancreatic beta cell, despite the widely variable concentrations at which a dose-action relationship is observed.
